Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionKestra Advisory Services, LLC
Latest Disclosed Ownership98,061 shares
Latest Disclosed Value $ 13,666,793
Kestra Advisory Services, LLC reports 3.06% increase in ownership of GILD / Gilead Sciences, Inc.

On April 30, 2026 - Kestra Advisory Services, LLC filed a 13F-HR form disclosing ownership of 98,061 shares of Gilead Sciences, Inc. (CH:GILD) valued at $13,666,793 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 95,154 shares of Gilead Sciences, Inc.. This represents a change in shares of 3.06% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F GILEAD SCIENCES COM 375558103 98,061 2,907 3.06 13,667 17.01 0.0517
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 95,154 36,524 62.30 11,679 79.48 0.0481
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 58,630 3,083 5.55 6,508 5.67 0.0298
2025-08-15 2025-06-30 13F GILEAD SCIENCES COM 375558103 55,547 -19,504 -25.99 6,158 -26.77 0.0300
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 75,051 -11,583 -13.37 8,409 5.09 0.0407
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 86,634 10,517 13.82 8,002 25.40 0.0437
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 76,117 -18,070 -19.19 6,382 5.44 0.0352
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 94,187 33,007 53.95 6,053 35.06 0.0338
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 61,180 6,316 11.51 4,481 0.83 0.0300
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 54,864 7,007 14.64 4,445 23.93 0.0360
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 47,857 8,417 21.34 3,586 18.00 0.0353
2023-08-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 39,440 -2,798 -6.62 3,040 -13.27 0.0304
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 42,238 -41,261 -49.41 3,504 -51.12 0.0380
2023-01-31 2022-12-31 13F GILEAD SCIENCES COM 375558103 83,499 9,338 12.59 7,168 179,100.00 0.0637
2022-11-01 2022-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 74,161 6,585 9.74 5 0.00 0.0490
2022-11-01 2022-09-30 13F GILEAD SCIENCES COM 375558103 74,161 6,585 4,575 0.0490
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 67,576 16,494 32.29 4 33.33 0.0429
2022-07-20 2022-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 51,082 -24,530 -32.44 3 -40.00 0.0316
2022-04-26 2022-03-31 13F GILEAD SCIENCES COM 375558103 51,082 -24,530 3,037 0.0316
2022-07-25 2021-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 75,612 2,161 2.94 5 0.00 0.0556
2022-01-20 2021-12-31 13F GILEAD SCIENCES COM 375558103 75,612 2,161 5,490 0.0556
2022-07-25 2021-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 73,451 18,542 33.77 5 66.67 0.0513
2021-10-19 2021-09-30 13F GILEAD SCIENCES COM 375558103 73,451 18,542 5,131 0.0513
2022-07-26 2021-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 54,909 1,310 2.44 4 0.00 0.0429
2021-07-28 2021-06-30 13F GILEAD SCIENCES COM 375558103 54,909 1,310 3,781 0.0429
2022-07-27 2021-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 53,599 1,460 2.80 3 50.00 0.0440
2021-05-10 2021-03-31 13F GILEAD SCIENCES COM 375558103 53,599 1,460 3,464 0.0440
2022-07-28 2020-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 52,139 7,770 17.51 3 -100.00 0.0342
2021-01-20 2020-12-31 13F GILEAD SCIENCES COM 375558103 52,139 7,770 2,954 0.0342
2022-07-29 2020-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 44,369 44,369 2,813,000 0.0525
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 44,369 44,369 2,813 0.0525
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.